A total of 400,000 doses of the Comirnaty mRNA vaccine against COVID-19, developed by Pfizer/BioNTech, were delivered to Ukraine this month under the framework of the EU-supported COVAX Facility.
The vaccines will be distributed throughout 23 regions in the country by the Ministry of Health of Ukraine.
“With the approach of the autumn/winter period, it is especially important to protect yourself from COVID-19, because as the experience of past years shows, the incidence increases sharply at this time,” said Ihor Kuzin, Deputy Minister of Health and Chief State Sanitary Doctor of Ukraine.
Ukraine joined COVAX with the support of Team Europe, the WHO, UNICEF and other international partners. The vaccines are being delivered by the UNICEF supply department.
Find out more
News
-
Seven key border crossing points in Ukraine equipped with uninterruptible power supply systems thanks to EU project
-
With EU support, Ukrzaliznytsia opens modernised train inspection point on the border with Poland at Mostyska II station
-
European Commission disburses first €3 billion of its part of G7 loan to Ukraine
-
EU announces €148 million humanitarian aid package for Ukraine
-
EU-funded reconstruction of Russian-destroyed kindergarten starts in Makariv, Ukraine
-
EIB provides €4.7 million for waste management improvements at Lviv’s Hrybovychi landfill